THE LIBRARY: EBOOK
Single Use Technology: From Bioprocess Convenience to Drug-Development Driver
In order to accelerate the production of biological molecules, companies have been exploring disposable, single-use systems. Download this ebook to learn the impact and future use of single-use technologies, cost-saving opportunities, and challenges of implementing new drug development processes.
Latest Commentary
Press Releases
- Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech
- Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013
- Statistical Challenges in Medical Device Trail Evaluation
- New drug enhances radiation treatment for brain cancer in preclinical studies
- Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S.
- More Press Releases
Featured Jobs
-
Sr. Manufacturing Process Lead Job
Celgene Corporation - Basking Ridge NJ US -
Senior Clinical Data Manager
Infinity Pharmaceuticals - Cambridge MA -
Sr. Manufacturing Process Lead Job
Celgene Corporation - Basking Ridge NJ US -
Research Associate - Biochemistry
Syros Pharmaceuticals - Watertown Massachusetts -
Senior Manager, QA Global Training Job
Celgene Corporation - Summit NJ US
Sponsored Links
ClearPoint MRI-guided device sheds light on drug delivery to the brain
This week, Tocagen began enrolling patients in a Phase I trial in which its Toca 511 cancer drug is delivered using a visually guided device called ClearPoint, the first such device of its kind, that allows for a more concentrated delivery, increasing the drug's effectiveness as much as threefold.
BIND Biosciences strives for 'revolutionary' nanomedicine
When it comes to drug delivery, it's hard these days to overlook the buzzing field of nanoengineering. Highly targeted nanoparticles are on the cutting edge of the growing field, and according to BIND Biosciences' Jeff Hrkach, there are big things in store for the tiny drug carriers.
Happy Holidays, and here's to a well-delivered 2013!
FierceDrugDelivery will be taking a brief break over the holidays, but we will be back Jan. 2.
pSivida--focusing on delivery to the eye
As people live longer, and as global demographics shift toward an older population, age-related eye diseases such as glaucoma and macular degeneration are increasing. The blood-eye barrier is very effective--this is useful in health, protecting such a sensitive organ, but an obstacle in disease as it makes it very hard to get drugs inside the eye. Because of these two factors, it is hardly surprising that companies such as pSivida ($PSDV) are focusing on ocular delivery.
Top 5 Insulin-Delivery Techs To Watch
With hundreds of millions of diabetes patients around the globe, the market for insulin delivery is vast and, according to the National Institutes of Health and others, ever-expanding. Couple that with healthcare reforms in the developing world that are bringing treatment to underserved populations, and it's no surprise that biotechs and drug delivery firms are turning their eyes to insulin as a possible cash cow.
Australia jumps into life sciences fray with R&D tax credit
You've heard about China and India becoming increasingly significant locales in the Asia-Pacific region for conducting biotechnology research and drug development. Australia, not so much.
Meet the new editor of FierceDrugDelivery
Hi! I'm Damian Garde, and I'm your new editor of FierceDrugDelivery.
Check out the new and improved FierceDrugDelivery website
We've completed a major overhaul of FierceDrugDelivery's website. Drop us a line with any suggestions or comments you may have.
Fierce's 5 Drug Delivery Companies to Watch
This year we're naming Fierce's 5 Drug Delivery Companies to Watch. All are making their mark by bringing drug delivery technology into everyday medical device and pharmaceutical use.
MIT's Robert Langer turned out to be a pretty mellow guy
After years of writing about companies with technology that stemmed from the mind of legendary MIT professor Robert Langer, I finally got to chat with him on the phone.